Minimally invasive implantation of left ventricular assist device HeartWare HVAD

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00062964" target="_blank" >RIV/00159816:_____/15:00062964 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00209775:_____/15:#0000313

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.crvasa.2015.02.011" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2015.02.011</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2015.02.011" target="_blank" >10.1016/j.crvasa.2015.02.011</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Minimally invasive implantation of left ventricular assist device HeartWare HVAD

Popis výsledku v původním jazyce

Introduction: Long-term left ventricular assist devices are nowadays part of standard therapy for patients in terminal phase of heart failure. Lower invasiveness of implantation might have the potential to enhance results of these high risk patients. Theaim of this study is to introduce our minimally invasive approach to the implantation of left ventricular assist device of the latest generation HeartWare ventricle assist device (HVAD) and our initial experience with this method. Methods: In our department we implanted HVAD between November 2013 and November 2014 in 8 patients as a bridge to heart transplantation. All patients were male with average age 59.5 6.4 years. Basic diseases were dilated cardiomyopathy in 6 patients (75%), ischemic cardiomyopathy in 2 patients (25%). The mean value of left ventricular ejection fraction was 10 3.6%, right ventricular ejection fraction was 35 5.6%. Access to the left ventricular apex was reached by left-sided thoracotomy of approximately 8 cm.

Název v anglickém jazyce

Minimally invasive implantation of left ventricular assist device HeartWare HVAD

Popis výsledku anglicky

Introduction: Long-term left ventricular assist devices are nowadays part of standard therapy for patients in terminal phase of heart failure. Lower invasiveness of implantation might have the potential to enhance results of these high risk patients. Theaim of this study is to introduce our minimally invasive approach to the implantation of left ventricular assist device of the latest generation HeartWare ventricle assist device (HVAD) and our initial experience with this method. Methods: In our department we implanted HVAD between November 2013 and November 2014 in 8 patients as a bridge to heart transplantation. All patients were male with average age 59.5 6.4 years. Basic diseases were dilated cardiomyopathy in 6 patients (75%), ischemic cardiomyopathy in 2 patients (25%). The mean value of left ventricular ejection fraction was 10 3.6%, right ventricular ejection fraction was 35 5.6%. Access to the left ventricular apex was reached by left-sided thoracotomy of approximately 8 cm.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

<a href="/cs/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: Fakultní nemocnice u sv. Anny v Brně - Mezinárodní centrum klinického výzkumu (FNUSA - ICRC)</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

57

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

5

Strana od-do

"e70"-"e74"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—